Variety of qualified patients: CDEC talked about the uncertainty in the volume of individuals with reasonably critical to critical hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific specialists consulted by CADTH indicated that some sufferers who will be categorized as owning mild or average ailment may have a critical https://madonnaf689zab3.slypage.com/profile